Breaking News, Collaborations & Alliances

Cytiva, Pear Bio Partner on Personalized Cancer Medicine

Will leverage Cytiva's Via Extractor tissue disaggregator to create dissociated tumor cell suspensions with high viability and yield.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Cytiva, a global life sciences company, and Pear Bio, a pioneer in personalized cancer medicine, are collaborating to advance cancer research and personalized treatment. Pear Bio is using Cytiva’s Via Extractor technology to create dissociated tumor cell suspensions with high viability and yield, revolutionizing tumor cell analysis.   Pear Bio processes tumor cells and matched patient immune cells, culturing them ex vivo in 3D environments to test the efficacy of FDA-approved therapies specifi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters